Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer
Clinical trial NCT04271384 · COMPLETED
Trial details
- NCT number
- NCT04271384
- Sponsor
- Hospital Israelita Albert Einstein
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2023-11-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.